ADC Weekly Digest - 1 to 3 May 2024

ADC Weekly Digest - 1 to 3 May2024

Regulatory
Pfizer and Genmab’s ADC Tivdak receives full FDA approval for recurrent or metastatic cervical cancer
Clinical
AstraZeneca, Daiichi tout Enhertu trial win in earlier, broader HER2-low breast cancer